Purchase of government bonds
The interest rate cut cycle is gaining momentum in the USD region. Inflation is expected to decline further, driven by housing and services. In the eurozone, inflation is already below 2%.
Government bonds are currently out of favour with investors. However, we see profit potential as the impact of declining inflation outweighs concerns about fiscal deficits in the short term. Contrary to consensus, we are raising the USD to neutral in the short term. For alternative investments, Swiss real estate is up, commodities are down. No changes are being made to equity allocations.
Author: Nicola Grass
Although inflation in the US has risen above 3% again, we believe this is only a temporary increase. Therefore, we consider a low-inflation scenario to be likely – both in the US and globally. Under these circumstances, we expect attractive returns on government bonds (except in Switzerland), as yields could decline. Additionally, governments will need to stabilise their budgets to avoid deterring investors. As a result, portfolios should include more bonds, including those from the US. This also allows for a higher weighting of the USD.
In the alternatives segment, we are making two adjustments: we are increasing the allocation to listed Swiss real estate, as year-end is seasonally positive and demand remains high in the zero-interest-rate environment. This is also reflected in the numerous oversubscribed capital increases.
We assess the outlook for commodities as moderate, for three reasons:
No changes are planned for equities. We remain slightly overweight as we view economic conditions, earnings growth, and financial conditions as favourable. A hotly debated topic is whether capital expenditures for data centres by major "hyperscalers" will pay off. While these investments are often self-financed, we see signs that financial flexibility may be reaching its limits. Indicators include massive debt financing by companies like Oracle and Meta, as well as the fact that investments now account for 70% of operating cash flow. Nonetheless, the megatrend of artificial intelligence (AI) continues to expand to other companies, both directly and indirectly. As such, IT and pharmaceuticals remain overweight in our portfolios. Regionally, emerging markets, particularly Asia, stand out with their strength in IT and large domestic markets.
“BLOOMBERG®” and the Bloomberg indices listed herein (the “Indices”) are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited (“BISL”), the administrator of the Indices (collectively, “Bloomberg”) and have been licensed for use for certain purposes by the distributor hereof (the “Licensee”). Bloomberg is not affiliated with Licensee, and Bloomberg does not approve, endorse, review, or recommend the financial products named herein (the “Products”). Bloomberg does not guarantee the timeliness, accuracy, or completeness of any data or information relating to the Products.